VLS Valneva SE

Declaration of shares and voting rights April 30, 2024 - VALNEVA SE

Declaration of shares and voting rights April 30, 2024 - VALNEVA SE

VALNEVA

Declaration of shares and voting rights

April 30, 2024

__________________________________________________________________________________________

Company name: VALNEVA

Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)

Regulated market of Euronext Paris - Compartment B

Declaration date: May 6, 2024

Number of shares

composing the share capital of Valneva
Total number of voting rights including suspended voting rights* Description of the change Date on which this change was recognized Total number of voting rights excluding suspended voting rights**
 



139,276,901



ordinary shares with a par value of €0.15 each
158,384,922  



Transfer into bearer form of 1,000,000 shares with double voting rights



 



Double voting rights granted on 1,350 ordinary shares
April 26, 2024



 



Between April 4 &

April 29, 2024
158,260,600

___________________________

* Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.

** Net (or exercisable at a General Meeting) voting rights.

Attachment



EN
06/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Valneva SE

 PRESS RELEASE

Valneva to Participate in Multiple Events at the 26th World Vaccine C...

Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC Lyon (France), March 26, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its participation in the upcoming 26th World Vaccine Congress, which will take place from March 31 to April 2, 2026 at the Walter E. convention center in Washington, D.C. Led by the Company´s Chief Executive Officer, Thomas Lingelbach, a team of Valneva´s senior executives will participate in multiple events throughout the conference. On April 1, 2026, at 9:40 am EST, Susan...

 PRESS RELEASE

Valneva participera à plusieurs événements lors du 25ème World Vaccin...

Valneva participera à plusieurs événements lors du 25ème World Vaccine Congress de Washington Lyon (France), le 26 mars 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins a annoncé aujourd'hui sa présence au 26ème World Vaccine Congress, qui se tiendra du 31 mars au 2 avril 2026 au Walter E. Convention Center à Washington, D.C. Sous la direction du directeur général de la Société, Thomas Lingelbach, des membres de l’équipe dirigeante de Valneva participeront à différents événements, durant le congrès. Le 1er avril 2026 à 14h40 (9h40 EST), Susanne E...

Martial Descoutures
  • Martial Descoutures

ResearchPool Subscriptions

Get the most out of your insights

Get in touch